Furthermore, patients on antipsychotic monotherapy were more likely to have been diagnosed with bipolar affective disorder (ICD 10: F31), whereas patients prescribed APP were more likely to receive schizophrenia diagnosis. This evidence concerns the gene APP and bipolar disorder.